coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Newton And Haydock PCN, St. Helens (LAD) · Health Inequalities Profile

    PCN U20349 · NHS Cheshire and Merseyside Integrated Care Board · 4 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    47,203

    Registered population

    60.8% aged 18–64

    19.9%

    Aged 65+

    ICB 19.0% · England 17.9%

    3.5%

    Ethnic minority (non-White)

    1.4% Asian · England 9.6%

    32.2%

    In IMD quintile 1

    ICB 31.9% · England 21.0%

    ~15,916

    Core20 residents (est.)

    Resident basis; registered basis ~15,370 · see page 3

    8,483

    Hypertension register

    +3.49% in 3 yrs · England +5.60%

    505

    SMI register

    22.2% of St. Helens (LAD)'s

    1,434

    COPD register

    Reviews -8.95% in 3 yrs

    Forecast to 2030

    9,247

    Hypertension patients, 2034

    +764 on today

    62.0%

    QRISK ≥20% on statins, 2034

    +0.24pp over 3 yrs

    4.9%

    Cancer prevalence, 2034

    England 4.5%

    Three things the board should see

    52.2%
    Asthma annual reviews lag all comparators.

    Only 52.2% of asthma patients had a review (England 65.7%, ICB 62.3%), leaving about 1,700 unreviewed, which may reflect recall gaps.

    -23.2%
    Heart failure reviews fell over three years.

    Heart failure reviews fell 23.2% over 2023 to 2025 (England +8.7%) to 61.4% (England 78.5%), which could reflect review capacity constraints.

    96.3%
    First-dose MMR exceeds the national target.

    At age 5, first-dose MMR reaches 96.3% (England 91.7%, target 95.0%), though second-dose uptake is 6.5 pp lower at 89.8%.

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    Older patients make up 19.9% of the list, exceeding England's 17.9%

    Newton and Haydock PCN serves 47,203 registered patients across four practices. Patients aged 65+ comprise 19.9% (9,413 patients), compared with 20.1% in St. Helens (LAD), 19.0% in NHS Cheshire and Merseyside ICB and 17.9% in England. Those aged 0-17 represent 19.3% (LAD 18.7%, ICB 19.2%, England 19.6%). Based on Census usual residents rather than GP lists, 96.5% are White (LAD 96.5%, ICB 93.0%, England 81.1%), leaving a 3.5% ethnic minority share. Unverified population projections forecast 1.6% growth to 2030 (LAD 1.6%, ICB 2.3%, England 2.3%), informing primary care capacity planning.

    Age profile

    0–1719.3%
    18–6460.8%
    65+19.9%

    65+: ICB 19.0%, England 17.9%

    Ethnicity

    White96.5%
    Asian1.4%
    Mixed1.2%
    Other0.5%
    Black0.4%

    Older people · falls rows are St. Helens (LAD) local-authority (LA) data, not PCN

    MeasureLocalNorth WestEnglandPeriod
    Falls admissions, 65+, per 100,000 (St. Helens LA)2,2082,0711,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)83.2%82.9%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)51.6%56.6%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (St. Helens LA)1,1431,0219552024/25
    Falls deaths, all ages, per 100,000 (St. Helens LA)24.818.214.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Core20 deprivation reaches 32.2% across the PCN, with all four practices exceeding England

    The PCN Core20 cohort is 32.2%, above England (21.0%) and the ICB (31.9%), though below St. Helens (38.5%). Weighted practice share is 32.6%, reflecting differing practice and resident bases. All four practices exceed England. By concentration, Modality St Helens leads at 37.7% (6,293 estimated patients), followed by Newton Practice at 34.0% (3,536) and Vista Road Surgery at 28.5% (2,444). By volume, Patterdale Lodge Med Ctre has 3,097 patients despite a 26.8% share. Inequalities planning requires balancing high-volume lists alongside concentrated deprivation.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Modality St37.7% · 6,293 patients
    Newton34.0% · 3,536 patients
    Vista Road28.5% · 2,444 patients
    Patterdale Lodge26.8% · 3,097 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    505

    SMI register

    1.05% recorded prevalence

    220

    Learning disability register

    0.46% recorded prevalence

    14

    Care homes, 546 beds

    In the PCN catchment

    11.7%

    Provide unpaid care

    St. Helens (LAD), Census 2021

    The PCN records 505 severe mental illness patients (1.1%, England 1.0%) and 220 on the learning disability register (0.5%, England 0.6%). Catchment services include 14 care homes with 546 beds. St. Helens borough recorded 20 rough sleepers in 2025 and an 11.7% unpaid care rate, which cannot be extrapolated to the PCN. Lower recorded learning disability prevalence may reflect diagnostic or recording variation; clinical register audits would test this.

    Severe mental illness: physical health checks

    Recorded SMI prevalence is 1.1% (505 patients). Published check elements show 80.1% had a blood pressure check (England 83.4%) and 76.7% had BMI recorded (England 82.1%). Lagging national rates may leave physical health risks unmonitored.

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    8,483

    Hypertension register

    +3.49%

    Register growth, 3 yrs

    St. Helens (LAD) +5.27% · England +5.60%

    +1.13pp

    BP control, under 80

    ≤140/90 · −2.86pp aged 80+

    +764

    More patients by 2030

    Forecast 9,247 (18.85%)

    Hypertension case-finding and control

    Recorded hypertension prevalence is 17.6% (8,483 patients), below St. Helens (18.7%) but above the ICB (16.8%) and England (15.2%), while three-year register growth of +3.5% trailed England (+5.6%). For monitoring, 86.3% had a recent blood pressure check (England 90.0%). Blood pressure control for patients under 80 is 63.2%, trailing St. Helens (65.9%), the ICB (66.4%) and England (67.8%). For patients aged 80 and over, control fell 2.9 pp over three years (England +1.8 pp) to 79.3% (England 81.2%). Across all ages, treatment to target is 66.2% (England 70.3%). Lower blood pressure control than comparators across age groups could reflect recall or titration gaps to evaluate locally.

    Lipids and statins

    Lipid therapy for QRISK ≥ 20% is 61.5% (St. Helens 62.1%, ICB 63.2%, England 63.6%), with three-year growth of +0.4% trailing England (+6.2%). CKD coverage is 68.2% (England 70.3%). Lower coverage than national rates may reflect opportunities to review high-risk cohorts.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 2026102,360£1.30£1.71£1.86£133,068
    Cardiovascular (all), 2025146,115£3.82£4.37£3.33£558,159

    In 2026, the PCN prescribed 102,360 lipid-regulating items at £1.30 per item, below St. Helens (£1.75), the ICB (£1.71) and England (£1.86), amounting to £57,322 less than at England's unit cost, across 102,360 items. Lower unit expenditure per item than comparators provides contextual cost context for prescribing discussions.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    −0.27%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    −4.45%

    Asthma prevalence, PCN 3-yr % change

    Asthma recorded prevalence is 8.0% (3,624 patients), above England's 6.6% and ICB's 7.0%, yet 12-month reviews reach only 52.2% (England 65.7%, ICB 62.3%), leaving about 1,700 patients unreviewed. Prescribing of asthma management items for ages 5-19 is 2,740 per 1,000 (England 1,488). COPD prevalence is 3.0% (1,434 patients; England 1.9%), but reviews fell 8.9% over 2023 to 2025 (England +2.8%) to 70.2% (England 76.4%). High disease prevalence combined with lagging annual reviews may indicate review capacity constraints, unverified locally.

    Cancer register and children's immunisation

    Cancer register prevalence is 4.1% (1,966 patients; England 3.8%). In Q1 2025/26 childhood immunisations, PCN coverage exceeds England, but a dose contrast emerges: MMR dose 1 at age 5 achieves 96.3% (England 91.7%, cohort 108), whereas MMR dose 2 drops to 89.8% (England 82.8%), a 6.5 pp drop below dose 1 and 5.2 pp below the 95.0% target. Slower second-dose uptake could reflect recall attrition, unverified locally.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months92.3%

    England 91.0%

    6-in-1 complete primary course at 24 months94.2%

    England 92.2%

    MMR dose 1 at 24 months93.3%

    England 88.3%

    MMR dose 2 at age 589.8%

    England 82.8%

    4-in-1 pre-school booster at age 590.7%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    55.5%

    Cheshire and Merseyside ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~2,640

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Cheshire and Merseyside ICBEnglandNo usable stageStaged cancers
    Lung40.4%33.8%11%2,354
    Breast87.1%85.4%11%2,083
    Prostate52.3%53.2%12%2,037
    Bowel44.9%47.0%16%1,674
    Skin cancer86.9%87.8%21%932

    Across NHS Cheshire and Merseyside ICB in 2022, 55.5% of staged cancers (7,482 of 13,490) were diagnosed at stage 1 or 2, in line with England (55.3%), with known stage recorded for 72.8% (13,490 of 18,522). This represents a 2.6 pp increase from 52.8% in 2013, though reaching the 75.0% national ambition would require about 2,640 extra early diagnoses annually across the ICB. ICB stage data reflects system pathways rather than PCN delivery. Locally, PCN cervical screening coverage is 69.1% (England 66.8%), but Modality St Helens records 62.9%. Practice-level screening variation could delay earlier cancer detection for registered patients.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    In July 2026 (provisional), Mersey and West Lancashire Teaching Hospitals NHS Trust achieved 78.0% on the 62-day cancer standard, exceeding the ICB (76.2%) and England (71.2%), but below North Cheshire and Mersey NHS Foundation Trust (83.7%). On the 28-day faster diagnosis standard, the trust achieved 72.4% against the 75.0% standard, trailing the ICB (77.2%) and England (79.3%). For 6+ week diagnostic waits, non-obstetric ultrasound was 23.3% (England 19.6%) and colonoscopy was 18.0% (England 30.8%). These provider waiting times reflect wider system performance rather than PCN delivery.

    Pathways within standard (%)Mersey and West LancashireNorth Cheshire and MerseyWrightington, Wigan and LeighCheshire and Merseyside ICBEngland
    28-day faster diagnosis (75%)72.3980.2182.8077.2579.32
    31-day treatment (96%)95.4698.1789.0495.7192.50
    62-day referral to treatment (85%)77.9683.6776.7876.2371.16
    Diagnostic waits over 6 weeks (%)Mersey and West LancashireNorth Cheshire and MerseyWrightington, Wigan and LeighEngland
    MRI14.040.530.4921.40
    CT13.082.327.789.92
    Echocardiography34.8828.0424.3728.48
    Colonoscopy18.0415.986.1030.83
    Gastroscopy18.1720.2412.5429.02
    All 15 DM01 tests21.176.3414.3623.14
    Community services activitySt. Helens residentsCheshire and Merseyside ICB
    Care contacts48,525541,280
    Referrals7,81597,150
    Patients with a contact12,745146,240

    Community services (residents of St. Helens), Jun 2026 (provisional). In June 2026 (provisional), St. Helens borough residents recorded 48,525 community service contacts, with 29,090 among adults aged 65 and over (59.9% of contacts). These figures reflect borough resident utilisation rather than PCN provision, indicating substantial community activity among older people across the wider local authority.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Practice telephone access spans 36.8 pp, with two practices trailing England

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Patterdale Lodge10626.860.8%67.7%78.5%
    Vista Road Surgery10328.563.5%75.5%73.4%
    Modality St Helens11037.726.6%75.2%63.4%
    Newton Practice9334.035.4%67.3%62.6%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNSt. Helens (LAD)AssetPCNSt. Helens (LAD)
    Care homes (catchment)14 (546 beds)n/aSchools (catchment)57n/a
    Children's centres38Places of worship3490
    Libraries515Primary schools (LA maintained)832
    Primary academies411Special schools12

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Structured asthma annual review recall

    Asthma reviews reach 52.2% of 3,624 patients, below St. Helens (58.2%), the ICB (62.3%) and England (65.7%), leaving 1,733 (about 1,700) unreviewed. For discussion: the PCN could trial a single recall template, offer flexible after-school or holiday slots, and review inhaler prescribing during annual reviews. Moderate effort to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Option 2

    Pre-school MMR second-dose recall

    In Q1 2025/26 (cohort 108), age-5 MMR coverage is 96.3% for dose 1 (England 91.7%) vs 89.8% for dose 2 (England 82.8%), a 6.5 pp gap (5.2 pp below the 95.0% target). Low cost, quick to run.

    Evidence base: coverage against the 95% target is the direct measure of programme delivery and catch-up need; where coverage clusters low, that decides whether catch-up is organised at practice, PCN, school or outreach level.

    Policy anchor: 10 Year Health Plan, shift from sickness to prevention.

    Option 3

    Learning disability register validation

    Recorded learning disability prevalence is 0.5% (220 of 47,203 patients), below the 0.6% in St. Helens, the ICB and England, a benchmark gap range of +45 to +57. For discussion: practices could audit clinical codes, validate registers against social-care records where data sharing exists, and send accessible annual check invitations. Moderate effort to run.

    Evidence base: the register is the cohort for the annual health check and LeDeR learning; people with a learning disability die on average 20 years earlier and are a Core20PLUS5 PLUS group.

    Policy anchor: annual health checks for 75% of people aged 14+ on the register (Network Contract DES); Oliver McGowan mandatory training.

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Learning disability register review (p2)Learning disability: QOF prevalence75% annual health checks (Network Contract DES) · Oliver McGowanPCN
    Two-track Core20 outreach (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    SMI physical health check recall (p4)SMI register with a BP check in the last 12 monthsMHIS · From Harm to HopePCN
    Hypertension control and recall audit (p5)Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN
    MMR second dose recall audit (p6)MMR dose 2 coverage at age 510YHP sickness to prevention · 95% targetPCN
    Cervical screening recall audit (p7)Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs)Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026Practice
    Practice telephone access review (p9)GPPS easy to contact the practice by phone10YHP, hospital to communityPractice
    Option 1 · Structured asthma annual review recall (p12)Asthma register · Patients with Asthma: review in the last 12 months (denominator incl. PCAs)Core20PLUS5 respiratoryPCN
    Option 2 · Pre-school MMR second-dose recall (p12)MMR dose 1 coverage at age 5 · MMR dose 2 coverage at age 510YHP sickness to prevention · 95% targetPCN
    Option 3 · Learning disability register validation (p12)Learning disability register · Learning disability: QOF prevalence · Registered population75% annual health checks (Network Contract DES) · Oliver McGowanPCN
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026Local authority2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15